Emiel J. Rutgers, MD

Emiel J. Rutgers, MD, surgical oncologist, Netherlands Cancer Institute, Amsterdam, describes the personalization of treatment for patients with early-stage breast cancer.

In this group of patients, a physician must look at the results of a sentinel node biopsy and consider the primary tumor characteristics. If there is low tumor involvement, a physician would most likely determine that no treatment of the axial is adequate. If a patient has more tumor involvement in the sentinel nodes and larger tumor burden in the breast, elective treatment of the axilla with radiotherapy is a good strategy.

In patients with low tumor involvement, no treatment of the axilla is adequate

In patients with more tumor involvement in the sentinel nodes, elective treatment of the axilla with radiotherapy is a good strategy

Videos

Emiel J. Rutgers, MD, from the Netherlands Cancer Institute, describes the personalization of treatment for patients with early-stage breast cancer.

Emiel J. Rutgers, MD | Authors

Articles

Personalizing Treatment of Early-Stage Breast Cancer